Stanford University
Showing 24,151-24,160 of 36,216 Results
-
Sonia Partap
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsMy research interests involve the epidemiology, treatment and diagnosis of pediatric and young adult brain tumors. I am also interested in long-term neurologic effects and designing clinical trials to treat brain and spinal cord tumors.
-
Gopanandan Parthasarathy
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr Nandan Parthasarathy is a hepatologist and physician-scientist in the Department of Gastroenterology and Hepatology at Stanford University.
After obtaining his medical degree in JIPMER, India, he completed a 2 year clinical research fellowship at Mayo Clinic, following which he completed his residency training at Cleveland Clinic, and GI and transplant hepatology fellowships at Mayo Clinic. During his fellowship, his research work was focused on exploring the immune mechanisms of liver injury in metabolic dysfunction associated steatohepatitis.
Clinically, he is focused on taking care of patients with MASH, cirrhosis and liver cancer.
His career goal is to study the gut-immune system-liver injury axis in order to bring novel therapeutics from the bench to bedside in patients with liver disease. -
Preethy Parthiban
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioMy research centers on how the innate immune system shapes tissue remodeling in health and disease. During my PhD, I uncovered a key role for resident macrophages in driving cardiac fibrosis, identifying a macrophage-derived chemokine that directly activates cardiac fibroblasts. Building on this foundation, my postdoctoral work at Stanford focuses on neutrophil–macrophage crosstalk in disrupted alveolarization in neonatal mice and patients. By integrating cellular, molecular, and translational approaches, I aim to define how innate immune pathways orchestrate extracellular matrix remodeling. Ultimately, my goal is to identify critical therapeutic targets that improve outcomes in ECM-related diseases.
